Literature DB >> 552863

Animal model for investigation of fluphenazine kinetics after administration of long-acting esters.

A C Altamura, R Whelpton, S H Curry.   

Abstract

A model was developed for studying fluphenazine availability and disposition. Rats were given doses of radioactively labelled esters of fluphenazine by intramuscular injection. Radioactivity excreted in urine, faeces, and expired air was assessed for fluphenazine esters, fluphenazine, and CO2 content. Levels of fluphenazine and its esters were measured in plasma, brain, and muscle (injected and non-injected samples). The data mimicked those obtained in other studies involving the same material given to human subjects, and posed new questions concerning the factors controlling fluphenazine availability when given as 'long-acting' intramuscular injections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 552863     DOI: 10.1002/bdd.2510010204

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  5 in total

Review 1.  Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications.

Authors:  S R Marder; J W Hubbard; T Van Putten; K K Midha
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Calcium-dependent signaling in Dupuytren's disease.

Authors:  Josef G Hadeed; Jennifer E Bond; M Angelica Selim; Andrew Bergeron; L Scott Levin; Howard Levinson
Journal:  Hand (N Y)       Date:  2010-12-15

Review 3.  Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.

Authors:  A Cario Altamura; Francesca Sassella; Annalisa Santini; Clauno Montresor; Sara Fumagalli; Emanuela Mundo
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

5.  Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.

Authors:  A C Altamura; S H Curry; S Montgomery; D H Wiles
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.